WASHINGTON UNIVERSITY, THE
SCOTTSDALE, Texas
Total Received
$2.55B
Total Awards
1K
State
Texas
Last Updated
Apr 22, 2026
Yearly Funding Trend
$2.21B24
$300.3M25
$39.1M26
Top 50 Awards to WASHINGTON UNIVERSITY, THE
Largest individual federal awards on record for this recipient, ranked by obligated amount. Data through April 22, 2026.
| Award | Awarding Agency | Program | Place | FY | Obligation |
|---|---|---|---|---|---|
ASST_NON_U24OD023121_075 PRECISION MEDICINE INITIATIVE COHORT PROGRAM BIOBANK - ENTER THE TEXT HERE THAT IS THE NEW ABSTRACT INFORMATION FOR YOUR APPLICATION. THIS SECTION MUST BE NO LONGER THAN 30 LINES… | Department of Health and Human Services National Institutes of Health | 93.368 21ST CENTURY CURES ACT - PRECISION MEDICINE INITIATIVE | MN-90 | 2024 | $180,342,068 |
ASST_NON_P30CA015083_075 MAYO CLINIC COMPREHENSIVE CANCER CENTER SUPPORT GRANT - MAYO CLINIC COMPREHENSIVE CANCER CENTER (MCCCC) IS THE ONLY NATIONAL CANCER INSTITUTE (NCI) DESIGNATED COMPREHENSIVE CANCER… | Department of Health and Human Services National Institutes of Health | 93.397 CANCER CENTERS SUPPORT GRANTS | MN-90 | 2024 | $106,749,839 |
ASST_NON_U10CA180882_075 ALLIANCE STATISTICS AND DATA MANAGEMENT CENTER - PROJECT SUMMARY THE ALLIANCE FOR CLINICAL TRIALS IN ONCOLOGY (ALLIANCE) WAS FOUNDED ON JULY 15, 2011, THROUGH THE MERGER OF 3 LEGA… | Department of Health and Human Services National Institutes of Health | 93.395 CANCER TREATMENT RESEARCH | ROCHESTER, MN-01 | 2024 | $95,540,927 |
ASST_NON_U19AG063911_075 ARTFL LEFFTDS LONGITUDINAL FRONTOTEMPORAL LOBAR DEGENERATION (ALLFTD) - ABSTRACT – ARTFL LEFFTDS LONGITUDINAL FTLD: OVERALL SECTION FRONTOTEMPORAL LOBAR DEGENERATION (FTLD) IS THE… | Department of Health and Human Services National Institutes of Health | 93.853 EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS | MN-90 | 2024 | $82,511,281 |
ASST_NON_UL1TR002377_075 MAYO CLINIC CENTER FOR CLINICAL AND TRANSLATIONAL SCIENCE (CCATS) - MAYO CLINIC IS ONE OF THE LARGEST NOT‐FOR‐PROFIT, ACADEMIC HEALTH SYSTEMS, TOP-RANKED FOR QUALITY MORE OFTEN TH… | Department of Health and Human Services National Institutes of Health | 93.350 NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES | MN-90 | 2024 | $70,838,088 |
ASST_NON_U01AG006786_075 ALZHEIMERS DISEASE PATIENT REGISTRY (ADMINISTRATIVE SUPPLEMENT) - PROJECT SUMMARY THIS ADMINISTRATIVE SUPPLEMENT REQUEST IS TO AUGMENT THE WORK OF THE MAYO CLINIC STUDY OF AGING (… | Department of Health and Human Services National Institutes of Health | 93.866 AGING RESEARCH | MN-90 | 2025 | $39,658,783 |
ASST_NON_P50CA116201_075 MAYO CLINIC BREAST CANCER SPORE - PROGRAM SUMMARY/ABSTRACT THIS THIRD RENEWAL APPLICATION OF THE MAYO CLINIC BREAST CANCER SPORE IS BEING SUBMITTED WITH THE VISION THAT THE BURDEN… | Department of Health and Human Services National Institutes of Health | 93.397 CANCER CENTERS SUPPORT GRANTS | ROCHESTER, MN-01 | 2024 | $38,450,771 |
ASST_NON_P50CA136393_075 MAYO CLINIC OVARIAN CANCER SPORE - PROJECT SUMMARY – OVERALL THIS REVISED APPLICATION OF THE MAYO CLINIC SPORE IN OVARIAN CANCER (OC) BUILDS ON TRANSLATIONAL RESEARCH CON- DUCTED… | Department of Health and Human Services National Institutes of Health | 93.397 CANCER CENTERS SUPPORT GRANTS | MN-90 | 2024 | $32,533,692 |
ASST_NON_P01AG062413_075 TARGETING CELLULAR SENESCENCE TO EXTEND HEALTHSPAN - OVERALL: TARGETING CELLULAR SENESCENCE TO EXTEND HEALTHSPAN – SUMMARY THIS PROPOSAL IS FOR THE RENEWAL OF P01 AG62413, TARGET… | Department of Health and Human Services National Institutes of Health | 93.866 AGING RESEARCH | ROCHESTER, MN-01 | 2024 | $25,141,194 |
ASST_NON_P30AG062677_075 MAYO ALZHEIMER'S DISEASE RESEARCH CENTER - PROJECT SUMMARY - OVERALL THE MAYO CLINIC ALZHEIMER’S DISEASE RESEARCH CENTER (ADRC) HAS BEEN OPERATING AT THE MAYO CLINIC ROCHESTER (MC… | Department of Health and Human Services National Institutes of Health | 93.866 AGING RESEARCH | MN-90 | 2024 | $24,495,299 |
ASST_NON_U01CA195568_075 THE LYMPHOMA EPIDEMIOLOGY OF OUTCOMES (LEO) COHORT STUDY - PROJECT SUMMARY IN 2020, AN ESTIMATED 77,240 PEOPLE IN THE US WILL BE DIAGNOSED WITH NON-HODGKIN LYMPHOMA (NHL), AND 19,… | Department of Health and Human Services National Institutes of Health | 93.393 CANCER CAUSE AND PREVENTION RESEARCH | ROCHESTER, MN-01 | 2024 | $22,101,202 |
ASST_NON_P30DK084567_075 MAYO CENTER FOR CELL SIGNALING IN GASTROENTEROLOGY - PROJECT SUMMARY THE OVERALL OBJECTIVE OF THE MAYO CLINIC CENTER FOR CELL SIGNALING IN GASTROENTEROLOGY (C-SIG) IS TO IMPROVE T… | Department of Health and Human Services National Institutes of Health | 93.847 DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH | MN-90 | 2024 | $19,809,546 |
ASST_NON_OT2OD039849_075 ALL OF US BIOBANK - IN 2017, THE ALL OF US (AOU) RESEARCH PROGRAM WAS ESTABLISHED TO REALIZE THE AMBITIOUS GOALS SET OUT BY THE PRECISION MEDICINE INITIATIVE PROPOSAL. THE GOAL OF… | Department of Health and Human Services National Institutes of Health | 93.310 TRANS-NIH RESEARCH SUPPORT | ROCHESTER, MN-01 | 2025 | $19,232,744 |
ASST_NON_U01NS100620_075 LONGITUDINAL IMAGING BIOMARKERS OF PRODROMAL DLB - PROJECT SUMMARY / ABSTRACT MILD COGNITIVE IMPAIRMENT (MCI) WITH CORE CLINICAL FEATURES OF DEMENTIA WITH LEWY BODIES (DLB) IS REC… | Department of Health and Human Services National Institutes of Health | 93.866 AGING RESEARCH | ROCHESTER, MN-01 | 2024 | $16,901,125 |
ASST_NON_P50CA210964_075 MAYO CLINIC HEPATOBILIARY SPORE - OVERALL – PROJECT SUMMARY THIS IS A RENEWAL OF THE NCI-SUPPORTED MAYO CLINIC SPORE IN HEPATOBILIARY CANCERS (HBC), WITH A FOUNDATION BUILT UPON I… | Department of Health and Human Services National Institutes of Health | 93.397 CANCER CENTERS SUPPORT GRANTS | ROCHESTER, MN-01 | 2024 | $15,914,851 |
ASST_NON_U01HG006379_075 EHR-BASED GENOMIC DISCOVERY AND IMPLEMENTATION [FUNDED EXTENSION] - IN PHASE IV OF EMERGE, A SINGLE, NETWORK-WIDE, COMBINED RISK ASSESSMENT AND MANAGEMENT PROTOCOL WAS IMPLEMENTED… | Department of Health and Human Services National Institutes of Health | 93.172 HUMAN GENOME RESEARCH | MN-90 | 2024 | $15,860,142 |
ASST_NON_K12CA090628_075 PAUL CALABRESI PROGRAM IN CLINICAL/TRANSLATIONAL RESEARCH AT MAYO CLINIC - THE MAYO CLINIC CANCER CENTER (MCCC) IS POISED TO PROVIDE AN EXCEPTIONAL CAREER DEVELOPMENT EXPERIENCE F… | Department of Health and Human Services National Institutes of Health | 93.398 CANCER RESEARCH MANPOWER | ROCHESTER, MN-01 | 2024 | $15,407,472 |
ASST_NON_KL2TR002379_075 INSTITUTIONAL CAREER DEVELOPMENT CORE - THE OVERALL OBJECTIVE OF THE CCATS KL2 INSTITUTIONAL CAREER DEVELOPMENT CORE IS TO PROVIDE SUPERB TRAINING TO INVESTIGATORS WHO CAN ASSUME… | Department of Health and Human Services National Institutes of Health | 93.350 NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES | ROCHESTER, MN-01 | 2024 | $13,574,607 |
ASST_NON_R01AG065154_075 BETA1-SELECTIVE BLOCKADE FOR PREVENTION OF POSTMENOPAUSAL BONE LOSS: A RANDOMIZED CONTROLLED TRIAL - OSTEOPOROSIS IS A DISEASE OF AGING THAT LEADS TO ~2 MILLION FRACTURES AND ~$17… | Department of Health and Human Services National Institutes of Health | 93.866 AGING RESEARCH | MN-90 | 2024 | $12,029,156 |
CONT_AWD_N0001419C2017_9700_-NONE-_-NONE- MISSION-SPECIFIC PHYSIOLOGIC AND ENVIRONMENTAL MONITORING | Department of Defense Department of the Navy | — | ROCHESTER, MN-01 | 2024 | $11,864,741 |
CONT_AWD_N0001419C2007_9700_-NONE-_-NONE- ADVANCED ELECTRONICS AND COMMUNICATIONS EFFORT | Department of Defense Department of the Navy | — | ROCHESTER, MN-01 | 2024 | $11,608,495 |
ASST_NON_U01DK115575_075 FECAL INCONTINENCE TREATMENT STUDY (FIT STUDY) - ABSTRACT THIS IS AN INITIAL APPLICATION FOR A U01 IN RESPONSE TO PAR-15-067. THIS PROGRAM ANNOUNCEMENT GREW OUT OF AN NIDDK WORKSH… | Department of Health and Human Services National Institutes of Health | 93.847 DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH | MN-90 | 2024 | $9,988,238 |
ASST_NON_R01DK090358_075 AUTOMATED DETECTION OF MICROSTRUCTURAL FEATURES THAT HAVE UNIQUE PROTEIN MARKERS AND ARE PROGNOSTIC FOR CHRONIC KIDNEY DISEASE - THE PRIMARY MICROSTRUCTURAL ATTRIBUTES SEEN IN “NO… | Department of Health and Human Services National Institutes of Health | 93.847 DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH | ROCHESTER, MN-01 | 2024 | $9,904,839 |
ASST_NON_R01HL098967_075 THE ROLE OF HYPOXIA IN VENOUS NEOINTIMAL HYPERPLASIA IN HEMODIALYSIS GRAFTS - PROJECT SUMMARY IN 2020, NEARLY 808,000 U.S. PATIENTS HAD END-STAGE KIDNEY DISEASE (ESKD) AND THE MAJ… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | MN-90 | 2024 | $9,653,066 |
ASST_NON_U24DK112326_075 MAYO CLINIC PHYSICAL ACTIVITY RESEARCH CENTER: METABOLOMICS AND PROTEOMICS ANALYSIS SITE - PROJECT SUMMARY MAYO CLINIC CHEMICAL CENTER (MCC) IS FUNDED TO PERFORM TARGETED METABOLI… | Department of Health and Human Services National Institutes of Health | 93.310 TRANS-NIH RESEARCH SUPPORT | ROCHESTER, MN-01 | 2024 | $8,876,405 |
ASST_NON_R01DK045343_075 REGIONAL FATTY ACID METABOLISM IN HUMANS - PROJECT SUMMARY/ABSTRACT THE LONG-TERM GOAL OF OUR RESEARCH IS TO UNDERSTAND HOW OBESITY, SPECIFICALLY UPPER BODY OBESITY (UBO), CAUSES… | Department of Health and Human Services National Institutes of Health | 93.847 DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH | ROCHESTER, MN-01 | 2024 | $8,837,584 |
ASST_NON_UM1CA233033_075 ENHANCED, EHR-FACILITATED CANCER SYMPTOM CONTROL (E2C2) PRAGMATIC CLINICAL TRIAL - CANCER AND ITS TREATMENT ENGENDER DISABLING SYMPTOMS THAT ARE FREQUENTLY UNDERTREATED, AND ASSOC… | Department of Health and Human Services National Institutes of Health | 93.353 21ST CENTURY CURES ACT - BEAU BIDEN CANCER MOONSHOT | ROCHESTER, MN-01 | 2024 | $8,698,201 |
ASST_NON_R01HL056470_075 NEONATAL MODULATION OF AIRWAY CONTRACTILITY - ABSTRACT PREMATURE BIRTH NECESSITATES INTERVENTIONS SUCH AS SUPPLEMENTAL O2 (HYPEROXIA; TYPICALLY <60% O2) WITH/WITHOUT RESPIRATORY S… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | ROCHESTER, MN-01 | 2024 | $8,601,789 |
ASST_NON_R01DK058816_075 ADPKD: DISEASE SPECTRUM & GENOTYPE-PHENOTYPE CORRELATIONS - AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD) IS A COMMON INHERITED DISORDER THAT RESULTS IN PROGRESSIVE RENAL I… | Department of Health and Human Services National Institutes of Health | 93.847 DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH | ROCHESTER, MN-01 | 2024 | $8,419,355 |
ASST_NON_U01CA210138_075 MAYO CLINIC PROSPECTIVE RESOURCE FOR BIOMARKER VALIDATION AND EARLY DETECTION OF PANCREATIC CANCER - PANCREATIC DUCTAL ADENOCARCINOMA (PDAC) IS TYPICALLY DETECTED AT LATE STAGE DU… | Department of Health and Human Services National Institutes of Health | 93.394 CANCER DETECTION AND DIAGNOSIS RESEARCH | MN-90 | 2024 | $8,248,315 |
ASST_NON_R01AR046849_075 BEYOND HEART DISEASE IN RHEUMATOID ARTHRITIS: MULTIMORBIDITY - PROJECT SUMMARY/ABSTRACT PATIENTS WITH RHEUMATOID ARTHRITIS (RA) CONTINUE TO EXPERIENCE A 30-40% EXCESS MORTALITY RI… | Department of Health and Human Services National Institutes of Health | 93.846 ARTHRITIS, MUSCULOSKELETAL AND SKIN DISEASES RESEARCH | ROCHESTER, MN-01 | 2024 | $8,202,554 |
ASST_NON_RC2DK118619_075 DISSECTING THE PATHOGENESIS AND OUTCOMES OF PSC USING MULTI-OMICS BY STUDYING THE EXPOSOME AND GENOME - PROJECT SUMMARY/ABSTRACT THE MAJOR GOAL OF THIS RC2 PROPOSAL IS TO GENERAT… | Department of Health and Human Services National Institutes of Health | 93.847 DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH | MN-90 | 2024 | $7,763,082 |
ASST_NON_R01DK078646_075 THE REGULATION OF FASTING GLUCOSE METABOLISM IN PEOPLE WITH AND WITHOUT PREDIABETES - THE OVERALL AIM OF THIS APPLICATION IS TO BETTER UNDERSTAND THE PATHOGENESIS OF FASTING HYPER… | Department of Health and Human Services National Institutes of Health | 93.847 DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH | MN-90 | 2024 | $7,729,198 |
ASST_NON_R01DK059597_075 INVESTIGATION OF COMMON DISEASE MECHANISMS IN NONSYNDROMIC AND SYNDROMIC PKD - POLYCYSTIC KIDNEY DISEASES (PKD) ARE A GROUP OF DISORDERS ASSOCIATED WITH DEFECTS IN PRIMARY CILIA A… | Department of Health and Human Services National Institutes of Health | 93.847 DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH | ROCHESTER, MN-01 | 2024 | $7,670,777 |
ASST_NON_U54AG044170_075 SEX-SPECIFIC EFFECTS OF ENDOCRINE DISRUPTION ON AGING AND ALZHEIMER'S DISEASE - OVERALL: SUMMARY/ABSTRACT MICHELLE M. MIELKE, PH.D. AGING-ASSOCIATED PHYSICAL AND COGNITIVE DECLINE… | Department of Health and Human Services National Institutes of Health | 93.866 AGING RESEARCH | MN-90 | 2025 | $7,647,925 |
ASST_NON_U19CA264362_075 CENTER OF INNOVATION FOR BRAIN TUMOR THERAPEUTICS - PROJECT DESCRIPTION/ABSTRACT – OVERALL THE DEVELOPMENT OF EFFECTIVE THERAPIES FOR GLIOBLASTOMA (GBM) HAS BEEN INCREDIBLY VEXIN… | Department of Health and Human Services National Institutes of Health | 93.395 CANCER TREATMENT RESEARCH | MN-90 | 2024 | $7,557,918 |
ASST_NON_R01HL092961_075 EPITHELIAL-MESENCHYMAL INTERACTIONS IN FIBROSIS RESOLUTION - PROJECT SUMMARY PULMONARY FIBROSIS (PF) REMAINS A MAJOR AND GROWING MEDICAL BURDEN WITH UNSATISFACTORY THERAPEUTIC OPT… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | ROCHESTER, MN-01 | 2024 | $7,377,285 |
ASST_NON_R01NS076491_075 COMPUTATIONAL AND BIOLOGICAL APPROACH TO FLOW DIVERSION - PROJECT SUMMARY THIS COMPETITIVE RENEWAL APPLICATION FOCUSES ON ADVANCING THE FIELD OF INTRACRANIAL FLOW DIVERSION (FDS),… | Department of Health and Human Services National Institutes of Health | 93.853 EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS | ROCHESTER, MN-01 | 2024 | $7,361,479 |
ASST_NON_U01TR002062_075 OPEN HEALTH NATURAL LANGUAGE PROCESSING COLLABORATORY - PROJECT SUMMARY ONE OF THE MAJOR BARRIERS IN LEVERAGING ELECTRONIC HEALTH RECORD (EHR) DATA FOR CLINICAL AND TRANSLATIONAL… | Department of Health and Human Services National Institutes of Health | 93.350 NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES | ROCHESTER, MN-01 | 2024 | $7,170,920 |
ASST_NON_RF1AG055549_075 MITOCHONDRIAL COMPLEX I AS A TARGET FOR NEUROPROTECTION IN AD - ALZHEIMER’S DISEASE (AD) HAS NO EFFECTIVE TREATMENTS, AND RECENT CLINICAL TRIALS FOCUSED ON PREVENTING OF AMY- LOID… | Department of Health and Human Services National Institutes of Health | 93.866 AGING RESEARCH | MN-90 | 2025 | $6,988,033 |
ASST_NON_R01AI110173_075 PRIME SHOCK AND KILL FOR HIV ERRADICATION - PROJECT SUMMARY WHEN PEOPLE ENCOUNTER AN INFECTIOUS AGENT OR A VACCINE FOR THE FIRST TIME, THEY DEVELOP AN IMMUNE RESPONSE TO THAT AGEN… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | MN-90 | 2024 | $6,945,215 |
ASST_NON_R01NS031744_075 STRUCTURE AND FUNCTION OF THE ACETYLCHOLINE RECEPTOR - ABSTRACT- MEMBERS OF THE NICOTINIC ACETYLCHOLINE RECEPTOR (ACHR) GENE FAMILY MEDIATE SYNAPTIC TRANSMISSION THROUGHOUT THE CE… | Department of Health and Human Services National Institutes of Health | 93.853 EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS | MN-90 | 2025 | $6,935,536 |
ASST_NON_R01AG044615_075 RESPIRATORY CONTROL IN OLD AGE - BY 2030, ~70 MILLION PEOPLE IN THE USA WILL BE >65 YEARS OLD WITH ~10 MILLION >85 YEARS OLD. THE STUDIES PROPOSED IN THIS COMPETITIVE RENEWAL APPL… | Department of Health and Human Services National Institutes of Health | 93.866 AGING RESEARCH | MN-90 | 2024 | $6,923,456 |
ASST_NON_R01EB017095_075 DIAGNOSTIC PERFORMANCE ASSESSMENT AND DOSE OPTIMIZATION USING PATIENT CT IMAGES: APPLICATION TO DEEP-LEARNING CT RECONSTRUCTION AND DENOISING TECHNOLOGIES - PROJECT SUMMARY/ABSTRA… | Department of Health and Human Services National Institutes of Health | 93.286 DISCOVERY AND APPLIED RESEARCH FOR TECHNOLOGICAL INNOVATIONS TO IMPROVE HUMAN HEALTH | ROCHESTER, MN-01 | 2024 | $6,846,877 |
ASST_NON_UG1CA232760_075 NCI, NATIONAL CLINICAL TRIALS NETWORK LEAD ACADEMIC PARTICIPATING SITE (LAPS) UG1 - PROJECT SUMMARY AS REFLECTED IN THIS APPLICATION, MAYO CLINIC HAS A LONG TRADITION OF CLINICAL… | Department of Health and Human Services National Institutes of Health | 93.395 CANCER TREATMENT RESEARCH | MN-90 | 2024 | $6,842,633 |
ASST_NON_R01HL081753_075 GENETIC STUDIES OF SARCOMERE-BASED CARDIAC DISEASES - PROJECT SUMMARY TITIN (TTN) TRUNCATING VARIANTS (TTNTVS) HAVE BEEN FOUND TO BE THE MOST COMMON GENETIC FACTOR FOR DILATED CA… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | ROCHESTER, MN-01 | 2024 | $6,756,450 |
ASST_NON_R01DK024031_075 PATHOBIOLOGY OF HEPATIC EPITHELIA - PROJECT SUMMARY/ABSTRACT OUR GOALS ARE TO CONTINUE TO CLARIFY THE PATHOGENESIS OF POLYCYSTIC LIVER DISEASE (PLD) AND DEVELOP EFFECTIVE THERAPIE… | Department of Health and Human Services National Institutes of Health | 93.847 DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH | ROCHESTER, MN-01 | 2024 | $6,752,225 |
ASST_NON_R01DK040484_075 FFA METABOLISM IN DIFFERENT TYPES OF HUMAN OBESITY - PROJECT SUMMARY/ABSTRACT OUR GOAL IS TO UNDERSTAND THE MECHANISMS BY WHICH OBESITY, AND SPECIFICALLY UPPER BODY/VISCERAL OBES… | Department of Health and Human Services National Institutes of Health | 93.847 DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH | ROCHESTER, MN-01 | 2024 | $6,716,553 |
ASST_NON_R01HL062150_075 PNEUMOCYSTIS: MACROPHAGE & EPITHELIAL ACTIVATION - ABSTRACT: PNEUMOCYSTIS JIROVECII PNEUMONIA (PJP) REMAINS A SIGNIFICANT CAUSE OF MORBIDITY AND MORTALITY IN AIDS1. DURING AIDS AN… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | MN-90 | 2024 | $6,643,757 |
ASST_NON_R01NS092625_075 SYNUCLEINOPATHIES – NOVEL TARGETS IN EARLY DIAGNOSIS, PATHOPHYSIOLOGY, AND THERAPEUTIC APPROACH - PROJECT SUMMARY/ABSTRACT PARKINSON'S DISEASE (PD), DEMENTIA WITH LEWY BODIES (DLB… | Department of Health and Human Services National Institutes of Health | 93.853 EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS | ROCHESTER, MN-01 | 2024 | $6,605,147 |
Top 50 awards shown, ranked by obligated amount. Dates reflect performance period; last-modified dates match USAspending.gov. Complete listings include all transaction history going back to FY2024.
Funding Agencies
View All→Industries
View All→12345678910
GENERAL MEDICAL AND SURGICAL HOSPITALS$43.4M
RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)$40.2M
RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY)$7.6M
OFFICES OF PHYSICIANS (EXCEPT MENTAL HEALTH SPECIALISTS)$2.3M
TESTING LABORATORIES AND SERVICES$769K
PROFESSIONAL AND MANAGEMENT DEVELOPMENT TRAINING$403K
COMPUTING INFRASTRUCTURE PROVIDERS, DATA PROCESSING, WEB HOSTING, AND RELATED SERVICES$354K
ALL OTHER PROFESSIONAL, SCIENTIFIC, AND TECHNICAL SERVICES$342K
RESEARCH AND DEVELOPMENT IN THE SOCIAL SCIENCES AND HUMANITIES$122K
RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)$92K
Federal Programs (CFDA)
View All→12345678910
93.866 — AGING RESEARCH$337.6M
93.847 — DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH$304.1M
93.837 — CARDIOVASCULAR DISEASES RESEARCH$236.7M
93.397 — CANCER CENTERS SUPPORT GRANTS$193.6M
93.368 — 21ST CENTURY CURES ACT - PRECISION MEDICINE INITIATIVE$180.6M
93.853 — EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS$178.9M
93.395 — CANCER TREATMENT RESEARCH$175.8M
93.350 — NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES$102.0M
93.393 — CANCER CAUSE AND PREVENTION RESEARCH$98.8M
93.855 — ALLERGY AND INFECTIOUS DISEASES RESEARCH$92.9M
Source: USAspending.gov · All Recipients · Texas